2016 Miami Breast Cancer Conference

Breast Cancer

Neoadjuvant Endocrine Therapy Vastly Underutilized by U.S. Clinicians

Neoadjuvant endocrine therapy in the management of breast cancer is woefully underutilized by U.S. clinicians, according to advocates of this approach who made their case at the 2016 Miami Breast Canc...

Breast Cancer

In Ductal Carcinoma in Situ, Benefit of Wider Margins Tied to Radiation Use

The relationship between margin width and risk of recurrence after breast-conserving surgery for ductal carcinoma in situ depends on the use of radiation, according to a surgical oncologist who sought...

Breast Cancer

Novel Strategies Emerging for Triple-Negative Breast Cancer

Compelling hypotheses are emerging about the mechanisms driving triple-negative breast cancer, and they are driving drug development in this area, according to Joyce O’Shaughnessy, MD, Celebrating Wom...

Advertisement

Advertisement



Advertisement

click me